Lubiprostone activates non-CFTR-dependent respiratory epithelial chloride secretion in cystic fibrosis mice

Kelvin Macdonald, Karen R. McKenzie, Mark J. Henderson, Charles E. Hawkins, Neeraj Vij, Pamela L. Zeitlin

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Periciliary fluid balance is maintained by the coordination of sodium and chloride channels in the apical membranes of the airways. In the absence of the cystic fibrosis transmembrane regulator (CFTR), chloride secretion is diminished and sodium reabsorption exaggerated. ClC-2, a pH- and voltage-dependent chloride channel, is present on the apical membranes of airway epithelial cells. We hypothesized that ClC-2 agonists would provide a parallel pathway for chloride secretion. Using nasal potential difference (NPD) measurements, we quantified lubiprostone-mediated Cl- transport in sedated cystic fibrosis null (gut-corrected), C57Bl/6, and A/J mice during nasal perfusion of lubiprostone (a putative ClC-2 agonist). Baseline, amiloride-inhibited, chloride-free gluconate-substituted Ringer with amiloride and low-chloride Ringer plus lubiprostone (at increasing concentrations of lubiprostone) were perfused, and the NPD was continuously recorded. A clear dose-response relationship was detected in all murine strains. The magnitude of the NPD response to 20 μM lubiprostone was -5.8 ± 2.1 mV (CF, n = 12), -8.1 ± 2.6 mV (C57Bl/6 wild-type, n = 12), and -5.3 ± 1.2 mV (AJ wild-type, n = 8). A cohort of ClC-2 knockout mice did not respond to 20 μM lubiprostone (n = 6, P = 0.27). In C57Bl/6 mice, inhibition of CFTR with topical application of CFTR inhibitor-172 did not abolish the lubiprostone response, thus confirming the response seen is independent of CFTR regulation. RT-PCR confirmed expression of ClC-2 mRNA in murine lung homogenate. The direct application of lubiprostone in the CF murine nasal airway restores nearly normal levels of chloride secretion in nasal epithelia.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Lung Cellular and Molecular Physiology
Volume295
Issue number5
DOIs
StatePublished - Nov 2008
Externally publishedYes

Fingerprint

Cystic Fibrosis
Chlorides
Fibrosis
Nose
Chloride Channels
Amiloride
Water-Electrolyte Balance
Membranes
Lubiprostone
Nasal Mucosa
Sodium Channels
Secretory Pathway
Knockout Mice
Sodium Chloride
Perfusion
Epithelial Cells
Sodium
Polymerase Chain Reaction
Lung
Messenger RNA

Keywords

  • Murine
  • Nasal potential difference
  • Prostone

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Physiology (medical)
  • Cell Biology
  • Physiology

Cite this

Lubiprostone activates non-CFTR-dependent respiratory epithelial chloride secretion in cystic fibrosis mice. / Macdonald, Kelvin; McKenzie, Karen R.; Henderson, Mark J.; Hawkins, Charles E.; Vij, Neeraj; Zeitlin, Pamela L.

In: American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 295, No. 5, 11.2008.

Research output: Contribution to journalArticle

Macdonald, Kelvin ; McKenzie, Karen R. ; Henderson, Mark J. ; Hawkins, Charles E. ; Vij, Neeraj ; Zeitlin, Pamela L. / Lubiprostone activates non-CFTR-dependent respiratory epithelial chloride secretion in cystic fibrosis mice. In: American Journal of Physiology - Lung Cellular and Molecular Physiology. 2008 ; Vol. 295, No. 5.
@article{30cadce3dec1446e9605602e5381c3f2,
title = "Lubiprostone activates non-CFTR-dependent respiratory epithelial chloride secretion in cystic fibrosis mice",
abstract = "Periciliary fluid balance is maintained by the coordination of sodium and chloride channels in the apical membranes of the airways. In the absence of the cystic fibrosis transmembrane regulator (CFTR), chloride secretion is diminished and sodium reabsorption exaggerated. ClC-2, a pH- and voltage-dependent chloride channel, is present on the apical membranes of airway epithelial cells. We hypothesized that ClC-2 agonists would provide a parallel pathway for chloride secretion. Using nasal potential difference (NPD) measurements, we quantified lubiprostone-mediated Cl- transport in sedated cystic fibrosis null (gut-corrected), C57Bl/6, and A/J mice during nasal perfusion of lubiprostone (a putative ClC-2 agonist). Baseline, amiloride-inhibited, chloride-free gluconate-substituted Ringer with amiloride and low-chloride Ringer plus lubiprostone (at increasing concentrations of lubiprostone) were perfused, and the NPD was continuously recorded. A clear dose-response relationship was detected in all murine strains. The magnitude of the NPD response to 20 μM lubiprostone was -5.8 ± 2.1 mV (CF, n = 12), -8.1 ± 2.6 mV (C57Bl/6 wild-type, n = 12), and -5.3 ± 1.2 mV (AJ wild-type, n = 8). A cohort of ClC-2 knockout mice did not respond to 20 μM lubiprostone (n = 6, P = 0.27). In C57Bl/6 mice, inhibition of CFTR with topical application of CFTR inhibitor-172 did not abolish the lubiprostone response, thus confirming the response seen is independent of CFTR regulation. RT-PCR confirmed expression of ClC-2 mRNA in murine lung homogenate. The direct application of lubiprostone in the CF murine nasal airway restores nearly normal levels of chloride secretion in nasal epithelia.",
keywords = "Murine, Nasal potential difference, Prostone",
author = "Kelvin Macdonald and McKenzie, {Karen R.} and Henderson, {Mark J.} and Hawkins, {Charles E.} and Neeraj Vij and Zeitlin, {Pamela L.}",
year = "2008",
month = "11",
doi = "10.1152/ajplung.90221.2008",
language = "English (US)",
volume = "295",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "5",

}

TY - JOUR

T1 - Lubiprostone activates non-CFTR-dependent respiratory epithelial chloride secretion in cystic fibrosis mice

AU - Macdonald, Kelvin

AU - McKenzie, Karen R.

AU - Henderson, Mark J.

AU - Hawkins, Charles E.

AU - Vij, Neeraj

AU - Zeitlin, Pamela L.

PY - 2008/11

Y1 - 2008/11

N2 - Periciliary fluid balance is maintained by the coordination of sodium and chloride channels in the apical membranes of the airways. In the absence of the cystic fibrosis transmembrane regulator (CFTR), chloride secretion is diminished and sodium reabsorption exaggerated. ClC-2, a pH- and voltage-dependent chloride channel, is present on the apical membranes of airway epithelial cells. We hypothesized that ClC-2 agonists would provide a parallel pathway for chloride secretion. Using nasal potential difference (NPD) measurements, we quantified lubiprostone-mediated Cl- transport in sedated cystic fibrosis null (gut-corrected), C57Bl/6, and A/J mice during nasal perfusion of lubiprostone (a putative ClC-2 agonist). Baseline, amiloride-inhibited, chloride-free gluconate-substituted Ringer with amiloride and low-chloride Ringer plus lubiprostone (at increasing concentrations of lubiprostone) were perfused, and the NPD was continuously recorded. A clear dose-response relationship was detected in all murine strains. The magnitude of the NPD response to 20 μM lubiprostone was -5.8 ± 2.1 mV (CF, n = 12), -8.1 ± 2.6 mV (C57Bl/6 wild-type, n = 12), and -5.3 ± 1.2 mV (AJ wild-type, n = 8). A cohort of ClC-2 knockout mice did not respond to 20 μM lubiprostone (n = 6, P = 0.27). In C57Bl/6 mice, inhibition of CFTR with topical application of CFTR inhibitor-172 did not abolish the lubiprostone response, thus confirming the response seen is independent of CFTR regulation. RT-PCR confirmed expression of ClC-2 mRNA in murine lung homogenate. The direct application of lubiprostone in the CF murine nasal airway restores nearly normal levels of chloride secretion in nasal epithelia.

AB - Periciliary fluid balance is maintained by the coordination of sodium and chloride channels in the apical membranes of the airways. In the absence of the cystic fibrosis transmembrane regulator (CFTR), chloride secretion is diminished and sodium reabsorption exaggerated. ClC-2, a pH- and voltage-dependent chloride channel, is present on the apical membranes of airway epithelial cells. We hypothesized that ClC-2 agonists would provide a parallel pathway for chloride secretion. Using nasal potential difference (NPD) measurements, we quantified lubiprostone-mediated Cl- transport in sedated cystic fibrosis null (gut-corrected), C57Bl/6, and A/J mice during nasal perfusion of lubiprostone (a putative ClC-2 agonist). Baseline, amiloride-inhibited, chloride-free gluconate-substituted Ringer with amiloride and low-chloride Ringer plus lubiprostone (at increasing concentrations of lubiprostone) were perfused, and the NPD was continuously recorded. A clear dose-response relationship was detected in all murine strains. The magnitude of the NPD response to 20 μM lubiprostone was -5.8 ± 2.1 mV (CF, n = 12), -8.1 ± 2.6 mV (C57Bl/6 wild-type, n = 12), and -5.3 ± 1.2 mV (AJ wild-type, n = 8). A cohort of ClC-2 knockout mice did not respond to 20 μM lubiprostone (n = 6, P = 0.27). In C57Bl/6 mice, inhibition of CFTR with topical application of CFTR inhibitor-172 did not abolish the lubiprostone response, thus confirming the response seen is independent of CFTR regulation. RT-PCR confirmed expression of ClC-2 mRNA in murine lung homogenate. The direct application of lubiprostone in the CF murine nasal airway restores nearly normal levels of chloride secretion in nasal epithelia.

KW - Murine

KW - Nasal potential difference

KW - Prostone

UR - http://www.scopus.com/inward/record.url?scp=57049147616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57049147616&partnerID=8YFLogxK

U2 - 10.1152/ajplung.90221.2008

DO - 10.1152/ajplung.90221.2008

M3 - Article

C2 - 18805957

AN - SCOPUS:57049147616

VL - 295

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 5

ER -